Search results for: "johnson johnson" (218 records) Johnson Matthey appoints new chairman Tim Stevenson OBE succeeds Sir John Banham Johnson & Johnson makes executive appointments Furthers succession plans to ensure sustainable future PRECOS and Janssen sign service agreement Will support development of cancer drugs J&J to proceed with Crucell offer Will offer approximately €1.75bn in cash Crucell puts temporary stop on shipments of two vaccines Possibility of sterility being compromised at plant in Korea Argenta to develop drug candidates for Janssen Collaboration could be worth more than €33.5m Johnson & Johnson to buy remaining Crucell shares Transaction will strengthen vaccines business of healthcare products manufacturer Ingredients Johnson Matthey buys Reaxa scavengers business The QuadraPure and QuadraSil product ranges will be combined with the established Smopex metal scavenging range to make up the newly formed Johnson Matthey Scavenging... Regulatory Anticancer agent – <b>satraplatin</b> Platinum-based drugs are important in chemotherapy, particularly in hormone-dependent cancers Crucell starts universal RSV vaccine programme The programme is the company’s latest move towards the commercialisation of a respiratory syncytial virus (RSV) vaccine Unicef awards Crucell US$110m order for paediatric vaccine Funding will enable Quinvaxem to be supplied to the developing world Crucell and GSK to develop malaria vaccine Seeking third party funding to advance programme into US clinical trial Packaging Johnson & Jorgensen launches pouches for transporting chemicals Johnsen & Jorgensen has launched a range of pouches in any size from 40g up to 5kg for shipping hazardous chemicals. Bristol-Myers Squibb to spin off stake in Mead Johnson Bristol-Myers Squibb will spin off its 83% holding in infant formula maker Mead Johnson in order to focus on its biopharmaceuticals business. Johnson & Johnson to cut workforce by 7% in restructure Johnson & Johnson is to trim layers of management, simplify business structures and processes and cut its workforce of roughly 117,000 by 6-7% in a global restructuring... Johnson & Johnson and Crucell to develop influenza therapies Johnson & Johnson has bought an 18% stake in biopharmaceutical company Crucell as part of a deal to collaborate on the development of vaccines for the treatment and prevention... Previous1…89101112 (current)1314Next
